Feasibility and Site Identification Powered by Data and Gen AI

About this session

Session: DATA ANALYTICS & GEN AI: NEW APPROACHES TO IMPROVE SITE SELECTION & ACTIVATION

Despite significant advancements in clinical trial processes and technology, the industry continues to face challenges in delivering medicines efficiently, on time, and at a lower cost. An efficient data and AI-driven feasibility approach, combining human insights, process, and technology has the potential to bring the patient into focus. However, the integration of AI into the development process presents its own set of challenges. Let's explore how AI can enhance clinical trial feasibility efforts and consider practical ways to approach the challenges of integrating AI into the development process.

Speaker

• CA

  Carole Ackermann

  EMEA Cluster Portfolio Head · Novartis Pharma

  Speaker